Effect of azithromycin on acute inflammatory lesions and colonic bacterial load in a murine model of experimental colitis

Digestive Diseases and Sciences

Volumn 55, Issue 8, 2010, Pages 2211-2218

  Pleško, Sanja ^a   Banić, Marko ^b   Plečko, Vanda ^a   Anić, Branimir ^a   Brkić, Tomislav ^a   Renata, Heinzl ^b   Rotkvić, Ivo ^a,b  

^a KBC Zagreb   (Croatia)

^b University of Zagreb   (Croatia)

Author keywords

Azithromycin; Bacterial biofilm; Experimental colitis; Inflammation; Inflammatory bowel disease

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; AZITHROMYCIN; METHYLPREDNISOLONE; METRONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; SKIN SENSITIZATION;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; COLITIS; COLON; INFLAMMATION; MALE; METHYLPREDNISOLONE; METRONIDAZOLE; MICE; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 77954424850     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1034-7     Document Type: Article

References (41)

1. BE Sands 2000 Therapy of inflammatory bowel disease Gastroenterology 118 68 82 10.1016/S0016-5085(00)70007-2
2. C Camma M Giunta M Rosselli M Cottone 1997 Mesalamine in the maintenance treatment of Crohn′s disease: a meta-analysis adjusted for confounding variables Gastroenterology 113 1465 1473 10.1053/gast.1997.v113.pm9352848 1:CAS:528:DyaK2sXnt1Olsrg%3D 9352848 (Pubitemid 27461232)
3. AH Steinhart BG Feagan CJ Wong M Vandervoort S Mikolainis K Croitoru E Seidman DJ Leddin A Bitton E Drouin A Cohen GR Greenberg 2002 Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial Gastroenterology 123 1 33 40 10.1053/gast.2002.34225 1:CAS:528:DC%2BD38Xmt1aiurc%3D 12105831 (Pubitemid 34747523)
4. SL Greenbloom AH Steinhart GR Greenberg 1998 Combination ciprofloxacin and metronidazole for active Crohn's disease Can J Gastroenterol 12 1 53 56 1:STN:280:DyaK1c3gs1SmtA%3D%3D 9544412 (Pubitemid 28105540)
5. MT Labro 1998 Anti-inflammatory activity of macrolides: a new therapeutic potential? J Antimicrob Chemother 41 Suppl 13 37 46 10.1093/jac/41.suppl-2.37 1:CAS:528:DyaK1cXisFGjt7c%3D 9579711 (Pubitemid 28152222)
6. I Shafran L Kugler FA El-Zaatari SA Naser J Sandoval 2002 Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease Dig Liver Dis 34 1 22 28 10.1016/S1590-8658(02)80055-X 1:CAS:528:DC%2BD38XjtFGmu7w%3D 11930899 (Pubitemid 34202051)
7. Allen SD, Emery CL, Siders JA. Clostridium. U:Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology Washington DC: ASM; 1999, pp 654-671.
8. T Brkić M Banić B Anić Z Grabarević I Rotkvić B Artuković M Duvnjak P Sikirić B Troskot DE Hernandez 1992 A model of inflammatory bowel disease induced by 2, 4-dinitrofluorobenzene in previously sensitized BALB-c mice Scand J Gastroenterol 27 184 188 10.3109/00365529208999946 1502479
9. M Banić T Brkić B Anić I Rotkvić Z Grabarević M Duvnjak B Troskot S Mihatov 1993 Effect of methylprednisolone on small bowell, spleen and liver changes in a murine model of inflammatory bowel disease Aliment Pharmacol Ther 7 201 206 8485274 (Pubitemid 23109468)
10. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC, eds. The Anaerobic Bacteria Color atlas and textbook of Diagnostic Microbiology. Philadelphia: Lippincott; 1997:709-784.
11. MM Hunter A Wang CL Hirota DM McKay 2005 Neutralizing Anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis J Immunol 174 7368 7375 1:CAS:528: DC%2BD2MXkt1Ols7w%3D 15905584 (Pubitemid 40705707)
12. B Anić T Brkić M Banić R Heinzl CS Dohoczky D Smucrossed d sign I Rotkvić M Buljevac 1997 Histopathologic features of T-cell mediated colonic injury induced with 2, 4-dinitrofluorobenzene in BALB/c mice Acta Med Croat 51 11 14
13. M Banic B Anic T Brkic N Ljubicic S Plesko C Dohoczky D Erceg M Petrovecki I Stipancic I Rotkvic 2002 Effect of cyclosporine in a murine model of experimental colitis Dig Dis Sci 47 6 1362 1368 10.1023/A:1015339018181 1:CAS:528:DC%2BD38XltFakurg%3D 12064814 (Pubitemid 34606642)
14. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC, eds. Introduction to microbiology: Part I: The role of the Microbiology Laboratory in the Diagnosis of Infectious Diseases:Guidelines to Practice and Management. Color atlas and textbook of Diagnostic Microbiology. Philadelphia: Lippincott; 1997:69-120.
15. Jousimies-Somer HR, Summanen PH, Finegold SM. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and Other Anaerobic Gram-Negative Rods and Cocci. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington DC: ASM Press; 1999:690-711.
16. Hillier SL, Moncla BJ. Peptostreptococcus, Propionibacterium, Lactobacillus, Actinomyces and Other Non-Sporeforming Anaerobic Gram-Positive Bacteria. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of Clinical Microbiology. Washington DC: ASM Press; 1999:672-687.
17. Dawson-Saunders B, Trapp RG. Basic and clinical biostatistics. London, New Jersey: Prentice-Hall; 1994.
18. W Strober IJ Fuss RS Blumberg 2002 The immunology of mucosal models of inflammation Annu Rev Immunol 20 495 549 10.1146/annurev.immunol.20.100301. 064816 1:CAS:528:DC%2BD38XjtlWgtLk%3D 11861611 (Pubitemid 34293433)
19. CO Elson RB Sartor GS Tennyson RH Riddell 1995 Experimental models of inflammatory bowel disease Gastroenterology 109 1344 1367 10.1016/0016-5085(95) 90599-5 1:STN:280:DyaK28%2FivFensw%3D%3D 7557106
20. WB Xiao YL Liu 2003 Changes of CD8+CD28- T regulatory cells in rat model of colitis induced by 2, 4-dinitrofluorobenzene World J Gastroenterol 9 11 2528 2532 1:CAS:528:DC%2BD3sXhtVSjtL3N 14606090
21. Nicolas Barnich Arlette Darfeuille-Michaud 2007 Role of bacteria in the etiopathogenesis of inflammatory bowel disease World J Gastroenterol 13 42 5571 5576 1:CAS:528:DC%2BD2sXhtlGqsrrN 17948930 (Pubitemid 350031476)
22. RB Sartor 1997 The influence of normal microbial flora on the development of chronic mucosal inflammation Res Immunol 148 567 576 10.1016/S0923-2494(98) 80151-X 1:STN:280:DyaK1c3kvVamsg%3D%3D 9588836 (Pubitemid 28179021)
23. JM Blondeau E DeCarolis KL Metzler GT Hansen 2002 The macrolides Expert Opin Investig Drugs 11 2 189 215 10.1517/13543784.11.2.189 1:CAS:528: DC%2BD38XhvVaqtr0%3D 11829712 (Pubitemid 34144867)
24. MT Labro 2000 Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin Microbiol Rev 13 4 615 650 10.1128/CMR.13.4.615-650.2000 1:CAS:528:DC%2BD3cXnslCgtbo%3D 11023961
25. MJ Parnham O Čulic V Eraković V Munić S Popović-Grle K Barišić M Bosnar K Brajša I Čepelak S Čužić I Glojnarić Z Manojlović R Novak-Mirčetić K Oresković V Pavičić-Beljak S Radošević M Sučić 2005 Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment Eur J Pharmacol 517 132 143 10.1016/j.ejphar.2005.05.023 1:CAS:528:DC%2BD2MXlslymsL4%3D 15964564 (Pubitemid 40916224)
26. MT Labro 1995 Interactions entre les agents anti-infectieux et les phagocytes Presse Med 24 992 998 1:STN:280:DyaK2Mzps1OitA%3D%3D 7667224
27. DM Rennick MM Fort 2000 Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation Am J Physiol Gastrointest Liver Physiol 278 6 G829 G833 1:CAS:528: DC%2BD3cXks1Kntbw%3D 10859210
28. Y Arabi F Dimock DW Burdon J Alexander-Wiliams MR Keighley 1979 Influence of neomycin and metronidazole on colonic microflora of volunteers J Antimicrob Chemother 5 531 537 10.1093/jac/5.5.531 1:CAS:528:DyaL3cXjsVCntg%3D%3D 115830 (Pubitemid 10235174)
29. RB Sartor 1997 The influence of normal microbial flora on the development of chronic mucosal inflammation Res Immunol 148 567 576 10.1016/S0923-2494(98) 80151-X 1:STN:280:DyaK1c3kvVamsg%3D%3D 9588836 (Pubitemid 28179021)
30. A Mahgoub A El-Medany A Mustafa M Arafah M Moursi 2005 Azithromycin and erythromycin ameliorate the extent of colonic d+amage induced by acetic acid in rats Toxicol Appl Pharmacol 205 1 43 52 10.1016/j.taap.2004.09.012 1:CAS:528:DC%2BD2MXktVGksrk%3D 15885263 (Pubitemid 40693268)
31. A Menozzi C Pozzoli E Poli M Lazzaretti A Cantoni D Grandi E Giovannini G Coruzzi 2005 Effect of the macrolide antibacterial drug, tylosin, on TNBS-induced colitis in the rat Pharmacology 74 3 135 142 10.1159/000084324 1:CAS:528:DC%2BD2MXkvVOntr0%3D 15756055 (Pubitemid 40981099)
32. T Yamada E Deitch RD Specian MA Perry RB Sartor MB Grisham 1993 Mechanisms of acute and chronic intestinal inflammation induced by indomethacin Inflammation 17 641 662 10.1007/BF00920471 1:CAS:528:DyaK2cXis1SrsLs%3D 7906675 (Pubitemid 23359088)
33. AJ Matute CA Schurink RM Krijnen A Florijn M Rozenberg-Arska IM Hoepelman 2002 Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers Eur J Clin Microbiol Infect Dis 21 6 427 431 10.1007/s10096-002-0728- y 1:CAS:528:DC%2BD38XmslOgu78%3D 12111597 (Pubitemid 34756916)
34. Canbakan B, Sentürk H, Tahan V, Yildirim B, Özbay G, Hatemi I, Oktay E: Neutrophil oxidative burst: A possible pathogenic mechanism for tissue damage in ulcerative colitis. Abstract book. Inflammatory bowel disease: Translation from basic research to clinical practice, Dubrovnik: Falk Symposium 140; 2004, A43.
35. Rainis T, Maor I, Lanir A, Lavy A. Oxidative stress and neutrophil superoxide release in patients with Crohn's disease: Distinction between active and non-active disease. Abstract book. Inflammatory bowel disease: Translation from basic research to clinical practice, Dubrovnik: Falk Symposium 140; 2004, A44.
36. M Popovic S Janicijevic-Hudomal B Kaurinovic J Rasic S Trivic 2009 Antioxidant effects of some drugs on ethanol-induced ulcers Molecules 14 816 826 10.3390/molecules14020816 19255541
37. A Swidsinski J Weber V Loening-Baucke LP Hale H Lochs 2005 Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease J Clin Microbiol 43 7 3380 3389 10.1128/JCM.43.7.3380-3389.2005 16000463 (Pubitemid 40981351)
38. N Barnich A Darfeuille-Michaud 2007 Role of bacteria in the etiopathogenesis of inflammatory bowel disease World J Gastroenterol 13 42 5571 5576 1:CAS:528:DC%2BD2sXhtlGqsrrN 17948930 (Pubitemid 350031476)
39. EJ Giamarellos-Bourboulis 2008 Macrolides beyond the conventional antimicrobials: A class of potent immunomodulators Int J Antimicrob Agents 31 1 12 20 10.1016/j.ijantimicag.2007.08.001 1:CAS:528:DC%2BD2sXhsVCgtbzK 17935949 (Pubitemid 350236720)
40. S Macfarlane JF Dillon 2007 Microbial biofilms in the human gastrointestinal tract J Appl Microbiol 102 5 1187 1196 10.1111/j.1365-2672. 2007.03287.x 1:STN:280:DC%2BD2s3ktVKhtA%3D%3D 17448154 (Pubitemid 46633431)
41. EJ Giamarellos-Bourboulis 2008 Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators Int J Antimicrob Agents 31 1 12 20 10.1016/j.ijantimicag.2007.08.001 1:CAS:528:DC%2BD2sXhsVCgtbzK 17935949 (Pubitemid 350236720)